Search Results

There are 1640 results for: content related to: Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects

  1. You have free access to this content
    Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors

    Cancer

    Volume 116, Issue 6, 15 March 2010, Pages: 1582–1591, Faye M. Johnson, Shruti Agrawal, Howard Burris, Lee Rosen, Navneet Dhillon, David Hong, Anne Blackwood-Chirchir, Feng R. Luo, Oumar Sy, Sanjeev Kaul and Alberto A. Chiappori

    Article first published online : 27 JAN 2010, DOI: 10.1002/cncr.24927

  2. You have free access to this content
    Dasatinib induces autophagic cell death in human ovarian cancer

    Cancer

    Volume 116, Issue 21, 1 November 2010, Pages: 4980–4990, Xiao-Feng Le, Weiqun Mao, Zhen Lu, Bing Z. Carter and Robert C. Bast Jr

    Article first published online : 13 JUL 2010, DOI: 10.1002/cncr.25426

  3. You have free access to this content
    Dasatinib treatment for Philadelphia chromosome-positive leukemias

    Cancer

    Volume 115, Issue 7, 1 April 2009, Pages: 1381–1394, Hanna Jean Khoury, François Guilhot, Timothy P. Hughes, Dong-Wook Kim and Jorge E. Cortes

    Article first published online : 4 FEB 2009, DOI: 10.1002/cncr.24155

  4. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model

    The Journal of Pathology

    Volume 230, Issue 4, August 2013, Pages: 430–440, Saadia A Karim, Helen Creedon, Hitesh Patel, Neil O Carragher, Jennifer P Morton, William J Muller, Thomas RJ Evans, Barry Gusterson, Owen J Sansom and Valerie G Brunton

    Article first published online : 9 JUL 2013, DOI: 10.1002/path.4202

  5. You have free access to this content
    Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: E916–E927, Nicole Hassold, Katharina Seystahl, Kristina Kempf, Doris Urlaub, Michael Zekl, Hermann Einsele, Carsten Watzl, Jörg Wischhusen and Ruth Seggewiss-Bernhardt

    Article first published online : 4 APR 2012, DOI: 10.1002/ijc.27537

  6. Dasatinib inhibits progenitor cell proliferation from polycythaemia vera

    European Journal of Clinical Investigation

    Volume 38, Issue 8, August 2008, Pages: 578–584, M. Wappl, E. Jaeger, B. Streubel, H. Gisslinger, I. Schwarzinger, P. Valent and L. Oehler

    Article first published online : 17 JUL 2008, DOI: 10.1111/j.1365-2362.2008.01982.x

  7. You have free access to this content
    Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure

    Cancer

    Volume 115, Issue 17, 1 September 2009, Pages: 3935–3943, Alfonso Quintás-Cardama, Fabio Pires De Souza Santos, Hagop Kantarjian, Susan O'Brien, Stefan Faderl, Ahmed Awais, Gautam Borthakur and Jorge Cortes

    Article first published online : 10 JUN 2009, DOI: 10.1002/cncr.24432

  8. You have free access to this content
    Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals

    British Journal of Haematology

    Volume 153, Issue 2, April 2011, Pages: 199–211, Alison M. MCCaig, Emilio Cosimo, Michael T. Leach and Alison M. Michie

    Article first published online : 24 FEB 2011, DOI: 10.1111/j.1365-2141.2010.08507.x

  9. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study

    Hematological Oncology

    Volume 31, Issue 3, September 2013, Pages: 156–163, Takayoshi Uchiyama, Naoya Sato, Miwako Narita, Akie Yamahira, Minami Iwabuchi, Tatsuo Furukawa, Hirohito Sone and Masuhiro Takahashi

    Article first published online : 29 OCT 2012, DOI: 10.1002/hon.2034

  10. You have free access to this content
    The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA

    European Journal of Immunology

    Volume 43, Issue 1, January 2013, Pages: 93–103, Haruyuki Fujita, Toshio Kitawaki, Takayuki Sato, Takahiro Maeda, Shimeru Kamihira, Akifumi Takaori-Kondo and Norimitsu Kadowaki

    Article first published online : 6 DEC 2012, DOI: 10.1002/eji.201242699

  11. You have free access to this content
    Ingredients in Fruit Juices Interact with Dasatinib Through Inhibition of BCRP: A New Mechanism of Beverage–Drug Interaction

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 1, January 2015, Pages: 266–275, Brett Fleisher, Jesse Unum, Jie Shao and Guohua An

    Article first published online : 21 NOV 2014, DOI: 10.1002/jps.24289

  12. You have free access to this content
    Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

    British Journal of Haematology

    Volume 144, Issue 2, January 2009, Pages: 195–205, Fei Fei, Yingzhe Yu, Anita Schmitt, Markus Thomas Rojewski, Baoan Chen, Marlies Götz, Hartmut Döhner, Donald Bunjes and Michael Schmitt

    Article first published online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07433.x

  13. You have free access to this content
    Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro

    British Journal of Haematology

    Volume 143, Issue 5, December 2008, Pages: 698–706, Lilian Amrein, Tiffany A. Hernandez, Cristiano Ferrario, James Johnston, Spencer B. Gibson, Lawrence Panasci and Raquel Aloyz

    Article first published online : 21 OCT 2008, DOI: 10.1111/j.1365-2141.2008.07418.x

  14. Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

    European Journal of Clinical Investigation

    Volume 39, Issue 12, December 2009, Pages: 1098–1109, C. Sillaber, H. Herrmann, K. Bennett, U. Rix, C. Baumgartner, A. Böhm, S. Herndlhofer, E. Tschachler, G. Superti-Furga, U. Jäger and P. Valent

    Article first published online : 9 SEP 2009, DOI: 10.1111/j.1365-2362.2009.02206.x

  15. Importance of Characterizing Determinants of Variability in Exposure: Application to Dasatinib in Subjects With Chronic Myeloid Leukemia

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1254–1269, Guowei Dai, Marc Pfister, Anne Blackwood-Chirchir and Amit Roy

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008320604

  16. You have free access to this content
    Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model

    International Journal of Cancer

    Volume 125, Issue 11, 1 December 2009, Pages: 2547–2555, Roberta Vitali, Camillo Mancini, Vincenzo Cesi, Barbara Tanno, Marta Piscitelli, Mariateresa Mancuso, Fabiola Sesti, Emanuela Pasquali, Bruno Calabretta, Carlo Dominici and Giuseppe Raschellà

    Article first published online : 28 MAY 2009, DOI: 10.1002/ijc.24606

  17. Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1+ leukemia

    American Journal of Hematology

    Volume 89, Issue 9, September 2014, Pages: 896–903, Lori A. Gardner, Jelena Klawitter, Mark A. Gregory, Vadym Zaberezhnyy, Dmitry Baturin, Daniel A. Pollyea, Naoko Takebe, Uwe Christians, Lia Gore, James DeGregori and Christopher C. Porter

    Article first published online : 19 JUN 2014, DOI: 10.1002/ajh.23776

  18. You have free access to this content
    The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo

    Journal of Bone and Mineral Research

    Volume 25, Issue 8, August 2010, Pages: 1759–1770, Kate Vandyke, Andrea L Dewar, Peter Diamond, Stephen Fitter, Christopher G Schultz, Natalie A Sims and Andrew CW Zannettino

    Article first published online : 11 MAR 2010, DOI: 10.1002/jbmr.85

  19. Fluorescent Visualization of Src by Using Dasatinib-BODIPY

    ChemBioChem

    Volume 15, Issue 9, June 16, 2014, Pages: 1317–1324, Dr. Michael L. Vetter, Dr. Zijuan Zhang, Dr. Shuai Liu, Dr. Jinhua Wang, HaeYeon Cho, Dr. Jianming Zhang, Prof. Wei Zhang, Prof. Nathanael S. Gray and Prof. Priscilla L. Yang

    Article first published online : 14 MAY 2014, DOI: 10.1002/cbic.201402010

  20. You have free access to this content
    Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy

    Cancer

    Volume 115, Issue 11, 1 June 2009, Pages: 2482–2490, Alfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, Susan O'Brien, Deborah Thomas, Gabriela Vidal-Senmache, William Wierda, Steven Kornblau and Jorge Cortes

    Article first published online : 11 MAR 2009, DOI: 10.1002/cncr.24257